This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Siegel RL, Miller KD, Jemal A. CA Cancer J Clin. 2018; 68:7–30.SiegelRLMillerKDJemalA20186873010.3322/caac.2144229313949Search in Google Scholar
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Cancer Res. 2014; 74: 2913–2921.RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLM2014742913292110.1158/0008-5472.CAN-14-015524840647Search in Google Scholar
American Cancer Society. Cancer facts & figures 2017.American Cancer SocietySearch in Google Scholar
Van der Rhee H, Coebergh JW, de Vries E. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer. 2013; 49:1422–1436.Van der RheeHCoeberghJWde VriesEIs prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies2013491422143610.1016/j.ejca.2012.11.00123237739Search in Google Scholar
Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011; 29:1599–1606.NgKSargentDJGoldbergRMMeyerhardtJAGreenEMPitotHCVitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N97412011291599160610.1200/JCO.2010.31.7255308297821422438Search in Google Scholar
Holick MF. Vitamin D deficiency. N Engl J Med, 2007; 357, 266–281.HolickMFVitamin D deficiency200735726628110.1056/NEJMra07055317634462Search in Google Scholar
Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW. Vitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence. J Cancer, 2016; 7, 232–240.JacobsETKohlerLNKunihiroAGJurutkaPWVitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence2016723224010.7150/jca.13403474787626918035Search in Google Scholar
Waterhouse M, Risch HA, Bosetti C, Anderson KE, Petersen GM, Bamlet WR, et al. Vitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium. Ann Oncol 2015; 26:1776–83.10.1093.WaterhouseMRischHABosettiCAndersonKEPetersenGMBamletWRVitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium201526177683.10.1093.10.1093/annonc/mdv236451122125977560Search in Google Scholar
Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013; 5:3993–4021.10.3390/nu5103993.MoukayedMGrantWBMolecular link between vitamin D and cancer prevention201353993402110.3390/nu5103993382005624084056Open DOISearch in Google Scholar
Jorde R, Grimnes G. Vitamin D and health: the need for more randomized controlled trials. J Steroid Biochem Mol Biol. 2015; 148:269–74.10.1016.JordeRGrimnesGVitamin D and health: the need for more randomized controlled trials20151482697410.1016.10.1016/j.jsbmb.2015.01.02125636723Search in Google Scholar
Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012; 97:614–22.10.1210.AvenellAMacLennanGSJenkinsonDJMcPhersonGCMcDonaldAMPantPRLong-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial)2012976142210.121010.1210/jc.2011-130922112804Search in Google Scholar
Grant WB. A Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 2017. Anticancer Res. 2018; 38:1121–1136.GrantWBA Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 20172018381121113610.21873/anticanres.12331Search in Google Scholar
Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010; 95:2630–2633.GallagherJCSaiAJVitamin D insufficiency, deficiency, and bone health2010952630263310.1210/jc.2010-0918290206220525913Search in Google Scholar
Cannon TL, Ford J, Hester D, Trump DL. The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer. Case Reports in Pancreatic Cancer Volume 2.1, 2016.CannonTLFordJHesterDTrumpDLThe Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer21201610.1089/crpc.2016.0003631968430631812Search in Google Scholar
Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O’Reilly EM, Fuchs C, Innocenti F, Venook AP; Alliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014: 6;106.Van LoonKOwzarKJiangCKindlerHLMulcahyMFNiedzwieckiDO’ReillyEMFuchsCInnocentiFVenookAPAlliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)2014610610.1093/jnci/dju185415543125099612Search in Google Scholar
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men J Natl Cancer Inst. 2006;5;98:451–459.GiovannucciELiuYRimmEBHollisBWFuchsCSStampferMJProspective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men200659845145910.1093/jnci/djj10116595781Search in Google Scholar
Cho M, Peddi PF, Ding K, Chen L, Thomas D, Wang J, et al. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J Transl Med. 2013; 11:206.ChoMPeddiPFDingKChenLThomasDWangJVitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma20131120610.1186/1479-5876-11-206384442324011168Search in Google Scholar
Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, et al. Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3. Tumour Biol. 2015; 36:2631–2640.HaasMKernCKrugerSMichlMModestDPGiessenCAssessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D32015362631264010.1007/s13277-014-2885-x25472579Search in Google Scholar
McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB. Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer. Nutr J. 2016; 15:17.McGovernEMLewisMENiesleyMLHuynhNHoagJBRetrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer2016151710.1186/s12937-016-0135-3475174626867933Search in Google Scholar
Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, et al. 25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014; 106.Van LoonKOwzarKJiangCKindlerHLMulcahyMFNiedzwieckiD25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)201410610.1093/jnci/dju185Search in Google Scholar
Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, et al. Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival. J Clin Oncol. 2016; 34:2899–2905.YuanCQianZRBabicAMorales-OyarvideVRubinsonDAKraftPPrediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival2016342899290510.1200/JCO.2015.66.3005501266227325858Search in Google Scholar
Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012; 23:363–370.TretliSSchwartzGGTorjesenPARobsahmTESerum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study20122336337010.1007/s10552-011-9885-6326140022193397Search in Google Scholar
Zhang X, Huang XZ, Chen WJ, Wu J, Chen Y, Wu CC, et al. Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget. 2017: 29; 8:64395–64406ZhangXHuangXZChenWJWuJChenYWuCCPlasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysi2017298643956440610.18632/oncotarget.18888561001128969079Search in Google Scholar
Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017; 12: e0170791.GakschMJordeRGrimnesGJoakimsenRSchirmerHWilsgaardTVitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium201712e017079110.1371/journal.pone.0170791531292628207791Search in Google Scholar
Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J. Vitamin D analogues: Potential use in cancer treatment. Crit Rev Oncol Hematol. 2017; 112:190–197DuffyMJMurrayASynnottNCO’DonovanNCrownJVitamin D analogues: Potential use in cancer treatment201711219019710.1016/j.critrevonc.2017.02.01528325259Search in Google Scholar
Van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, et al. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Int J Cancer. 2018; 15; 142:1189–1201.Van DuijnhovenFJBJenabMHveemKSiersemaPDFedirkoVDuellEJCirculating concentrations of vitamin D in relation to pancreatic cancer risk in European populations2018151421189120110.1002/ijc.31146581321929114875Search in Google Scholar
Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15:1688–1695.SkinnerHGMichaudDSGiovannucciEWillettWCColditzGAFuchsCSVitamin D intake and the risk for pancreatic cancer in two cohort studies2006151688169510.1158/1055-9965.EPI-06-020616985031Search in Google Scholar
Stolzenberg-Solomon RZ, Vieth R, Azad A, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006; 66:10213–10219.Stolzenberg-SolomonRZViethRAzadAA prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers200666102131021910.1158/0008-5472.CAN-06-187617047087Search in Google Scholar
Stolzenberg-Solomon RZ, Hayes RB, Horst RL, et al. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009; 69:1439–1447.Stolzenberg-SolomonRZHayesRBHorstRLSerum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial2009691439144710.1158/0008-5472.CAN-08-2694305220019208842Search in Google Scholar